"Weight reducing or anti-obesity drugs, currently available, ought to be used very judiciously," the Minister said while addressing the inaugural session of the 2-day "Asia Oceania Conference on ...
The top 5 most-read dermatology content of 2025 on AJMC.com included innovative advances from artificial intelligence ...
While childhood obesity has become more common in recent years, this is a condition that is about more than just weight.
Since the pandemic in the early 2020s, people have been dealing with collective stressors. This has included social isolation ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...
Proving her illness created an illusion of wellness for columnist Ahna Crum, but a relapse after nine years showed her she ...
In 2025, the FDA approved 73 first-time generic drugs. Here are the generics and their indication, in order of approval date: Note: The FDA’s information is current as of Dec. 18. 1. Phytonadione ...
Fear of relapse and worsening disease is common for MS patients, leading to poorer mental health, per a study calling for ...
An analysis of major depressive disorder, covering diagnostic criteria, prevalence statistics across demographics, and ...
When the Holidays Trigger Addiction and How to Stay in Recovery | Oz Health The holidays can be especially hard for people in ...
Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis ...
Good Housekeeping on MSN
What It's Like to Navigate Dating as Someone With OCD
After years of spiraling thoughts and second-guessing myself, I learned how to open up without letting fear take over.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback